Basic Information
Basic information for MAP4K3-DT-214-36aa
Peptide Name MAP4K3-DT-214-36aa
Genome Position chr2:39601203-39601310[+]
Species Human
Peptide Sequence MKEHSGPGTVAHACNPSTLGGPGGRITRSGDRDHPG
Peptide Length 36
Unique No (MAP4K3-DT-204-36aa,MAP4K3-DT-210-36aa,MAP4K3-DT-211-36aa,MAP4K3-DT-212-36aa,MAP4K3-DT-213-36aa,MAP4K3-DT-215-36aa,MAP4K3-DT-216-36aa,MAP4K3-DT-217-36aa,MAP4K3-DT-218-36aa)
Grand Average of Hydropathicity -0.9611
Relative Molecular Mass 4241.59
Experimental Evidences 2:IRES,ribo
lncRNA ID/Name ENSG00000231312;MAP4K3-DT
Transcript ID/Name ENST00000658319;MAP4K3-DT-214
Transcript Length 2765
Coding Ability 0.2615
DNA Sequence Corresponding to Peptide ATGAAAGAACATTCTGGGCCGGGCACGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCCCAGGTGGGCGGATCACAAGGTCAGGAGATCGAGACCATCCTGGC
Experimental Evidences
   IRES
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :